Outside the Supreme Court, lines began forming nearly a week ago. By Monday, the line had snaked down the court steps and to the corner, with people braving freezing temperatures and snow in anticipation of the historic arguments on same-sex marriage on Tuesday and Wednesday.
The justices are first hearing a constitutional challenge to California's ban on same-sex marriage. A second day is devoted to the federal Defense of Marriage Act, which denies federal benefits to same-sex couples married in the nine states where such unions are legal.
As the national spotlight turns to the U.S. Supreme Court this week with two historic arguments on same-sex marriage, the court on Monday made headlines on another high-profile issue: affirmative action.
Just 10 years ago a narrow court majority upheld affirmative action programs in higher education in an opinion written by Justice Sandra Day O'Connor. But ever since O'Connor retired and was replaced by the more conservative Justice Samuel Alito, the court has been on a steady march to get rid of all race-conscious programs.
Credit Saul Loeb/AFP/ Getty Images and Charles Dharapak/AP / NPR
If you have any interest in politics at all, you pretty much know two things. One, that the next presidential election, on Nov. 8, 2016, is only 1,324 days away. And two, you won't be surprised if people are focusing on it in March of 2013.
Sometimes the speculation is silly, but sometimes it's not. Judging from what we've seen and heard from Hillary Clinton and Rand Paul, the speculation may be on target.
The U.S. Supreme Court hears arguments Monday in a case worth billions of dollars to pharmaceutical companies and American consumers. The issue is whether brand-name drug manufacturers may pay generic drug manufacturers to keep generics off the market. These payments — a form of settlement in patent litigation — began to blossom about a decade ago when the courts, for the first time, appeared to bless them.